Audit of the efficacy and complications of cyanoacrylate glue embolisation to treat varicose veins in primary care
Isaac Weaver 1 , Paul Weaver 1 21 0800VEINDR, 811 Heretaunga St., East Hastings 4122, New Zealand.
2 Corresponding author. Email: paul.weaver@0800veindr.com
Journal of Primary Health Care 11(3) 249-258 https://doi.org/10.1071/HC19001
Published: 6 September 2019
Journal Compilation © Royal New Zealand College of General Practitioners 2019. This is an open access article licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Abstract
INTRODUCTION: Cyanoacrylate glue embolization (CAGE) is a non-surgical procedure that uses a proprietary medical adhesive, delivered endovenously to close truncal, varicose veins.
AIM: To describe CAGE administered by a New Zealand general practitioner (GP) in primary care.
METHODS: The procedures were performed by a single GP with a special interest and 19 years’ clinical experience in procedural phlebology. The clinical records of 107 consecutive patients who underwent CAGE over a 2-year period were retrospectively reviewed. Some patients had bilateral disease and some had more than one truncal vein per leg treated. Data on 173 truncal veins were included in the audit. Clinical data, procedural details and postprocedural course were recorded and analysed for 71 females and 36 males.
RESULTS: In total, 173 truncal veins were treated. They included the anterior accessory saphenous vein, the great saphenous vein, the small (lesser) saphenous vein and the thigh extension with a range of clinical severity. The most commonly treated truncal vein was the great saphenous vein with an average truncal diameter of 8.8 mm (2.9 s.d.). Of the 173 treated truncal veins, two failed to seal with CAGE, but were sealed after adjuvant ultrasound-guided foam sclerotherapy treatment. Post CAGE, 14.5% of treated truncal veins developed a phlebitis.
DISCUSSION: This audit shows that varicose veins can be treated in general practice with high levels of anatomic efficacy and few adverse effects.
KEYwords: Clinical audit; Venaseal™; varicose veins; phlebitis; special interest; general practitioner
References
[1] Rose SS, Ahmed A. Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg (Torino). 1986; 27 534–43.[2] Guex JJ. Thrombotic complications of varicose veins: a literature review of the role of superficial venous thrombosis. Dermatol Surg. 1996; 22 378–82.
| Thrombotic complications of varicose veins: a literature review of the role of superficial venous thrombosis.Crossref | GoogleScholarGoogle Scholar | 8624665PubMed |
[3] Sarin S, Scurr JH, Smith PC. Stripping of the long saphenous vein in the treatment of primary varicose veins. Br J Surg. 1994; 81 1455–8.
| Stripping of the long saphenous vein in the treatment of primary varicose veins.Crossref | GoogleScholarGoogle Scholar | 7820469PubMed |
[4] Murad MH, Coto-Yglesias F, Zumaeta-Garcia M, et al. A systematic review and meta-analysis of the treatments of varicose veins. J Vasc Surg. 2011; 53 49S–65S.
| A systematic review and meta-analysis of the treatments of varicose veins.Crossref | GoogleScholarGoogle Scholar | 21536173PubMed |
[5] Rasmussen LH, Lawaetz M, Bjoern L, et al. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg. 2011; 98 1079–87.
| Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins.Crossref | GoogleScholarGoogle Scholar | 21725957PubMed |
[6] de Maeseneer MM. Endovenous thermal ablation for varicose veins: strengths and weaknesses. Phlebolymphology. 2012; 19 163–9.
[7] Gale SS, Lee JN, Walsh ME, et al. A randomized, controlled trial of endovenous thermal ablation using the 810-nm wavelength laser and the ClosurePLUS radiofrequency ablation methods for superficial venous insufficiency of the great saphenous vein. J Vasc Surg. 2010; 52 645–50.
| A randomized, controlled trial of endovenous thermal ablation using the 810-nm wavelength laser and the ClosurePLUS radiofrequency ablation methods for superficial venous insufficiency of the great saphenous vein.Crossref | GoogleScholarGoogle Scholar | 20638231PubMed |
[8] Schoonover JP, King JT, Gray C, et al. 3 alternatives to standard varicose vein treatment: for many patients with chronic venous insufficiency, thermal and chemical ablation could mean less pain and a speedier recovery. J Fam Pract. 2009; 58 522–26.
| 19874730PubMed |
[9] Proebstle TM, Alm J, Dimitri S, et al. The European ulticentre cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg. 2015; 3 2–7.
| 26993674PubMed |
[10] Tekin Aİ, Tuncer ON, Memetoğlu ME, et al. Nonthermal, nontumescent endovenous treatment of varicose veins. Ann Vasc Surg. 2016; 36 231–5.
| Nonthermal, nontumescent endovenous treatment of varicose veins.Crossref | GoogleScholarGoogle Scholar | 27421205PubMed |
[11] Gibson K, Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular. 2017; 25 149–56.
| Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study).Crossref | GoogleScholarGoogle Scholar | 27206470PubMed |
[12] Park I, Jeong MH, Park CJ, et al. Clinical features and management of “phlebitis-like abnormal reaction” after cyanoacrylate closure for the treatment of incompetent saphenous veins. Ann Vasc Surg. 2019; 55 239–45.
| Clinical features and management of “phlebitis-like abnormal reaction” after cyanoacrylate closure for the treatment of incompetent saphenous veins.Crossref | GoogleScholarGoogle Scholar | 30217712PubMed |
[13] Alm J. VenaSeal™ closure treatment of saphenous varicosis. Phlebologie. 2014; 43 242–8.
| VenaSeal™ closure treatment of saphenous varicosis.Crossref | GoogleScholarGoogle Scholar |
[14] London NJ, Nash R. Varicose veins. BMJ. 2000; 320 1391–4.
| Varicose veins.Crossref | GoogleScholarGoogle Scholar | 10818035PubMed |
[15] Park I. Initial outcomes of cyanoacrylate closure, Venaseal System, for the treatment of the incompetent great and small saphenous veins. Vasc Endovascular Surg. 2017; 51 545–9.
| Initial outcomes of cyanoacrylate closure, Venaseal System, for the treatment of the incompetent great and small saphenous veins.Crossref | GoogleScholarGoogle Scholar | 28969499PubMed |
[16] Morrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015; 61 985–94.
| Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose).Crossref | GoogleScholarGoogle Scholar | 25650040PubMed |
[17] Allegra C, Antignani PL, Bergan JJ, et al. The “C” of CEAP: suggested definitions and refinements: an International Union of Phlebology conference of experts. J Vasc Surg. 2003; 37 129–31.
| The “C” of CEAP: suggested definitions and refinements: an International Union of Phlebology conference of experts.Crossref | GoogleScholarGoogle Scholar | 12514589PubMed |
[18] Rabe E, Pannier F. Clinical, aetiological, anatomical and pathological classification (CEAP): gold standard and limits. Phlebology. 2012; 27 114–18.
| Clinical, aetiological, anatomical and pathological classification (CEAP): gold standard and limits.Crossref | GoogleScholarGoogle Scholar | 22312077PubMed |
[19] Labropoulos N, Tiongson J, Pryor L. Definition of venous reflux in lower-extremity veins. J Vasc Surg. 2003; 38 793–8.
| Definition of venous reflux in lower-extremity veins.Crossref | GoogleScholarGoogle Scholar | 14560232PubMed |
[20] Evans CJ, Allan PL, Lee AJ, et al. Prevalence of venous reflux in the general population on duplex scanning: the Edinburgh vein study. J Vasc Surg. 1998; 28 767–76.
| Prevalence of venous reflux in the general population on duplex scanning: the Edinburgh vein study.Crossref | GoogleScholarGoogle Scholar | 9808843PubMed |
[21] Navarro TP, Delis KT, Ribeiro AP. Clinical and hemodynamic significance of the greater saphenous vein diameter in chronic venous insufficiency. Arch Surg. 2002; 137 1233–7.
| Clinical and hemodynamic significance of the greater saphenous vein diameter in chronic venous insufficiency.Crossref | GoogleScholarGoogle Scholar | 12413308PubMed |
[22] Tang TY, Tiwari A. The VenaSeal™ abnormal red skin reaction: looks like but is not phlebitis! Eur J Vasc Endovasc Surg. 2018; 55 841
| The VenaSeal™ abnormal red skin reaction: looks like but is not phlebitis!Crossref | GoogleScholarGoogle Scholar | 29503084PubMed |
[23] Ikeda M, Kambayashi JI, Iwamoto SI, et al. Hemostasis activation during sclerotherapy of lower extremity varices. Thromb Res. 1996; 82 87–95.
| Hemostasis activation during sclerotherapy of lower extremity varices.Crossref | GoogleScholarGoogle Scholar | 8731513PubMed |
[24] Almeida JI, Javier JJ, Mackay EG, et al. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg. 2017; 5 658–66.
| 28818217PubMed |
[25] Kolluri R, Gibson K, Cher D, et al. Roll-in phase analysis of clinical study of cyanoacrylate closure for incompetent great saphenous veins. J Vasc Surg. 2016; 4 407–15.
| 27638993PubMed |
[26] Morrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015; 61 985–94.
| Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose).Crossref | GoogleScholarGoogle Scholar | 25650040PubMed |
